Federal Register Notice: FDA is making available a guidance, Administrative Procedures for CLIA Categorization. It describes the administrative aspects of categorizing commercially available in vitro diagnostic tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). The guidance discusses what manufacturers should submit to help expedite CLIA categorization by FDA. To download this guidance, click here. To view this notice, click here.
